Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

ACTIV: A Public-Private Partnership to Speed COVID-19 Therapies and Vaccines

Session Chair(s)

Robin M. Weinick, PhD

Robin M. Weinick, PhD

SVP/Managing Director Americas and Global Program Officer

DIA, United States

The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership brings together senior leaders from the Foundation for the National Institutes of Health (FNIH), NIH, FDA, BARDA, CDC, EMA, and the pharmaceutical industry to advance vaccines and therapies for COVID-19. The goal for the ACTIV partnership is to develop a framework to prioritize vaccine and therapeutic candidates in development and connect clinical trial networks to test new and repurposed candidates. In this session, representatives from the NIH, BARDA, EMA, FDA, and industry will provide an overview of the activities that are being undertaken by the ACTIV partnership.

Learning Objective : Describe how government and industry are collaborating to develop an international strategy for a coordinated research response to the COVID-19 pandemic; Discuss how a collaborative framework will prioritize vaccine and drug candidates, streamline clinical trials, coordinate regulatory processes, and/or leverage assets.

Speaker(s)

Peter W. Marks, MD, PhD

FDA Update

Peter W. Marks, MD, PhD

FDA, United States

Director, Center for Biologics Evaluation and Research

Thomas  Hudson, MD

Industry Update

Thomas Hudson, MD

AbbVie, United States

Senior Vice President, Research and Development, and Chief Scientific Officer

David  Wholley, MA

FNIH Update

David Wholley, MA

Foundation for National Institutes of Health (FNIH), United States

Senior Vice President of Research Partnerships

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.